legal-news

Taiho Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al

21-cv-00838
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

Taiho Pharmaceutical Co. and its co-plaintiffs sued MSN Laboratories Private Ltd. and co-defendants in a case docketed as 21-cv-00838, almost certainly a Hatch-Waxman patent infringement action tied to a generic drug application. The case has now reached a stipulation of dismissal at docket entry 164, indicating the parties have resolved their dispute. With 164 docket entries spanning from 2021, this was a fully litigated pharmaceutical patent matter. Hatch-Waxman settlements typically involve a negotiated market entry date for the generic manufacturer, though the specific terms here are not on the public record.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

  • • Hatch-Waxman patent infringement claims
  • • Validity and enforceability of Taiho's pharmaceutical patents
  • • Generic market entry date negotiated in settlement
  • • Antitrust implications of any reverse payment settlement terms
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
Advertisement

Case Timeline

1 event
info
Other April 20, 2026

1:21-cv-00838 Taiho Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al

The parties filed a joint stipulation.

description View filing open_in_new
Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

2 hours, 8 minutes ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.